Skip to content

Olfactive Stimulation Interventions With Mothers' Milk on Preterm Pain Response

Effectiveness of Olfactive Stimulation Interventions With Mothers' Milk on Preterm Pain Response: a Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04062513
Enrollment
96
Registered
2019-08-20
Start date
2019-09-30
Completion date
2020-12-31
Last updated
2019-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Milk, Pain, Acute, Preterm Infant

Brief summary

Repeated and untreated pain can lead to long-term consequences in preterm infants, such as pain hypersensitivity and impaired motor and intellectual development. Studies on the pharmacological and non-pharmacological interventions for pain management in preterm infants are limited. Thus, we investigated an intervention based on olfactive stimulation with mothers' milk. The aims of this study are: a) Evaluate the effectiveness of an olfactive stimulation intervention with mothers' milk odor on preterm procedural pain; b) Evaluate the effectiveness of adding a period of familiarization previous to the olfactive stimulation intervention with mothers' milk odor on preterm procedural pain. Preterm infants will be recruited and randomly assigned to three groups 1) mothers' milk odor during the nine hours before and during heel-prick, 2) mothers' milk odor during heel-prick, 3) standard care. Pain will be measured using a scale of pain adapted for preterm infants. This procedure with mothers'milk odor is inexpensive and easily performed.This study will significantly contribute to the advancement of knowledge on preterm infants pain management.

Interventions

OTHEROlfactive stimulation intervention with familiarization

The intervention consists of placing a pad immersed with breast milk near the preterm infant's nose during heel prick. For the familiarization stage, infants were familiarized with the odor of their mothers' milk for 9 hours before heel prick.

OTHEROlfactive stimulation intervention

The intervention consists of placing a pad immersed with breast milk near the preterm infant's nose during heel prick.

OTHERStandard care

Preterm infants will receive sucrose during heel prick.

Sponsors

St. Justine's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
29 Weeks to 36 Weeks
Healthy volunteers
Yes

Inclusion criteria

for mothers * 18 years or older, * speak, understand and write French or English * express their milk

Exclusion criteria

for mothers \- pathology or condition that contraindicates the use of their breast milk (HIV, drugs...) Inclusion Criteria for preterm * 29 to 36 weeks of gestation * APGAR \> 6 at 5 minutes * less than 21 days

Design outcomes

Primary

MeasureTime frameDescription
Pain : Premature Infant Pain Profile-RevisedChange from baseline every 30 seconds until 120 seconds post heel lance and 30 seconds after the end of blood collectionScores range from 0 to 21 where a higher score means more pain, a score less than 6 signifies an absence of pain, and a score greater than 12 indicates moderate to severe pain. The PIPP-R contains four parts: gestational age, state of sleep-awake, physiological parameters, and behavioural parameters.

Secondary

MeasureTime frameDescription
RecoveryThe time required for the preterm infant to return to baseline heart rate levels (should not exceed 5 minutes)
Maternal acceptability of the olfactive stimulation intervention : questionnaireImmediately post-procedureAfter the intervention, mothers will be asked to complete a questionnaire focusing on maternal acceptability of the olfactive stimulation intervention with mothers' milk to manage procedural pain (demographic questions and Likert scale).

Contacts

Primary ContactGwenaelle De Clifford-Faugère, PhD student
gwenaelle.de.clifford@umontreal.ca514 343-6111
Backup ContactMarilyn Aita, PhD
marilyn.aita@umontreal.ca514 343-6111

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026